{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antidiabetic activity", "diabetes mellitus", "experimental testing", "in vitro", "in vivo"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38747157", "DateRevised": {"Year": "2024", "Month": "05", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1111/fcp.13009"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "15"}], "Journal": {"ISSN": "1472-8206", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "May", "Day": "15"}}, "Title": "Fundamental & clinical pharmacology", "ISOAbbreviation": "Fundam Clin Pharmacol"}, "ArticleTitle": "Experimental approaches for induction of diabetes mellitus and assessment of antidiabetic activity: An in vitro and in vivo methodological review.", "Abstract": {"AbstractText": ["Diabetes mellitus poses a global health challenge, driving the need for innovative therapeutic solutions. Experimental methods play a crucial role in evaluating the efficacy of potential antidiabetic drugs, both in vitro and in vivo. Yet concerns about reproducibility persist, necessitating comprehensive reviews.", "This review aims to outline experimental approaches for inducing diabetes and evaluating antidiabetic activity, synthesizing data from authoritative sources and academic literature.", "We conducted a systematic search of prominent databases, including PubMed, ScienceDirect, and Scopus, to identify relevant articles spanning from 1943 to the present. A total of 132 articles were selected for inclusion in this review, focusing on in vitro and in vivo experimental validations of antidiabetic treatments.", "Our review highlights the diverse array of experimental methods employed for inducing diabetes mellitus and evaluating antidiabetic interventions. From cell culture assays to animal models, researchers have employed various techniques to study the effectiveness of novel therapeutic agents.", "This review provides a comprehensive guide to experimental approaches for assessing antidiabetic activity. By synthesizing data from a range of sources, we offer valuable insights into the current methodologies used in diabetes research. Standardizing protocols and enhancing reproducibility are critical for advancing effective antidiabetic treatments."], "CopyrightInformation": "\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et de Th\u00e9rapeutique. Published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Biotechnology, Medicinal Plants Research Centre, Islamic Azad University, Isfahan (Khorasgan) Branch, Isfahan, Iran."}], "LastName": "Gavanji", "ForeName": "Shahin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Reproductive Biology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Bakhtari", "ForeName": "Azizollah", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, Minia, Egypt."}], "LastName": "Abdel-Latif", "ForeName": "Rania", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Biocenter, University of W\u00fcrzburg, W\u00fcrzburg, Germany."}], "LastName": "Bencurova", "ForeName": "Elena", "Initials": "E"}, {"Identifier": ["0000-0003-4781-9745"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Biocenter, University of W\u00fcrzburg, W\u00fcrzburg, Germany."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt."}], "LastName": "Othman", "ForeName": "Eman M", "Initials": "EM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Fundam Clin Pharmacol", "NlmUniqueID": "8710411", "ISSNLinking": "0767-3981"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sattar N. Advances in the clinical management of type 2 diabetes: a brief history of the past 15\u2009years and challenges for the future. BMC Med. 2019;17(1):46. doi:10.1186/s12916\u2010019\u20101281\u20101"}, {"Citation": "Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol. 2013;4:37. doi:10.3389/fendo.2013.00037"}, {"Citation": "De Tata V. Age\u2010related impairment of pancreatic beta\u2010cell function: pathophysiological and cellular mechanisms. Front Endocrinol. 2014;5:138."}, {"Citation": "Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843"}, {"Citation": "Grammatiki M, Karras S, Kotsa K. The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review. Hormones (Athens). 2019;18(1):37\u201048. doi:10.1007/s42000\u2010018\u20100063\u2010z"}, {"Citation": "Lo\u2010Ciganic W, Zgibor JC, Ruppert K, Arena VC, Stone RA. Identifying type 1 and type 2 diabetic cases using administrative data: a tree\u2010structured model. J Diabetes Sci Technol. 2011;5(3):486\u2010493. doi:10.1177/193229681100500303"}, {"Citation": "Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol. 2020;11:1582. doi:10.3389/fimmu.2020.01582"}, {"Citation": "Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185\u20101200. doi:10.7150/ijms.10001"}, {"Citation": "Galaviz KI, Narayan KMV, Lobelo F, Weber MB. Lifestyle and the prevention of type 2 diabetes: a status report. Am J Lifestyle Med. 2018;12(1):4\u201020. doi:10.1177/1559827615619159"}, {"Citation": "Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet (London, England). 2014;383(9933):1999\u20102007. doi:10.1016/S0140\u20106736(14)60613\u20109"}, {"Citation": "Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the \u03b2\u2010cell (do not blame the immune system?). Nat Rev Endocrinol. 2021;17(3):150\u2010161. doi:10.1038/s41574\u2010020\u201000443\u20104"}, {"Citation": "Soleimanpour SA, Stoffers DA. The pancreatic \u03b2 cell and type 1 diabetes: innocent bystander or active participant? Trends Endocrinol Metab. 2013;24(7):324\u2010331. doi:10.1016/j.tem.2013.03.005"}, {"Citation": "Chiang JL, Maahs DM, Garvey KC, et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018;41(9):2026\u20102044. doi:10.2337/dci18\u20100023"}, {"Citation": "Gavanji S, Bakhtari A, Famurewa AC, Othman EM. Cytotoxic activity of herbal medicines as assessed in vitro: a review. Chem Biodivers. 2023;20(2):e202201098. 10.1002/cbdv.202201098"}, {"Citation": "Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia. 2002;45(3):309\u2010326. doi:10.1007/s00125\u2010001\u20100728\u2010y"}, {"Citation": "Dedoussis GV, Kaliora AC, Panagiotakos DB. Genes, diet and type 2 diabetes mellitus: a review. Rev Diab Stud: RDS. 2007;4(1):13\u201024. doi:10.1900/RDS.2007.4.13"}, {"Citation": "Mambiya M, Shang M, Wang Y, et al. The play of genes and non\u2010genetic factors on type 2 diabetes. Front Public Health. 2019;7:349. doi:10.3389/fpubh.2019.00349"}, {"Citation": "Kubota N, Kubota T, Itoh S, et al. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab. 2008;8(1):49\u201064. doi:10.1016/j.cmet.2008.05.007"}, {"Citation": "Guo S, Copps KD, Dong X, et al. The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol. 2009;29(18):5070\u20105083. doi:10.1128/MCB.00138\u201009"}, {"Citation": "Saito M, Hayakawa A, Inagaki N, Matsuoka H. Development of novel cell lines of diabetic dysfunction model fit for cell\u2010based screening tests of medicinal materials. Cytotechnology. 2013;65(1):105\u2010118. doi:10.1007/s10616\u2010012\u20109466\u2010x"}, {"Citation": "Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR. PDX\u20101 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest. 2004;114(6):828\u2010836. doi:10.1172/JCI21845"}, {"Citation": "Terauchi Y, Iwamoto K, Tamemoto H, et al. Development of non\u2010insulin\u2010dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate\u20101 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest. 1997;99(5):861\u2010866. doi:10.1172/JCI119250"}, {"Citation": "Shih DQ, Heimesaat M, Kuwajima S, Stein R, Wright CV, Stoffel M. Profound defects in pancreatic \u03b2\u2010cell function in mice with combined heterozygous mutations in Pdx\u20101, Hnf\u20101\u03b1, and Hnf\u20103\u03b2. Proc Natl Acad Sci USA. 2002;99(6):3818\u20103823. doi:10.1073/pnas.062605899"}, {"Citation": "Pedica F, Beccari S, Pedron S, et al. PDX\u20101 (pancreatic/duodenal homeobox\u20101 protein 1). Pathologica. 2014;106:315\u2010321."}, {"Citation": "Al\u2010Quobaili F, Montenarh M. Pancreatic duodenal homeobox factor\u20101 and diabetes mellitus type 2 (review). Int J Mol Med. 2008;21(4):399\u2010404. doi:10.3892/ijmm.21.4.399"}, {"Citation": "Shaw LM. The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer. Cell Cycle. 2011;10(11):1750\u20101756. doi:10.4161/cc.10.11.15824"}, {"Citation": "Kovacs P, Hanson RL, Lee YH, et al. The role of insulin receptor substrate\u20101 gene (IRS1) in type 2 diabetes in Pima Indians. Diabetes. 2003;52(12):3005\u20103009. doi:10.2337/diabetes.52.12.3005"}, {"Citation": "Zhang Y, Pan Y, Li J, et al. Inhibition on \u03b1\u2010glucosidase activity and non\u2010enzymatic glycation by an anti\u2010oxidative proteoglycan from Ganoderma lucidum. Molecules (Basel, Switzerland). 2022;27(5):1457."}, {"Citation": "Vhora N, Naskar U, Hiray A, Kate AS, Jain A. Recent advances in in\u2010vitro assays for type 2 diabetes mellitus: an overview. Rev Diab Stud: RDS. 2020;16(1):13\u201023. doi:10.1900/RDS.2020.16.13"}, {"Citation": "Feingold KR. Oral and injectable (non\u2010insulin) pharmacological agents for the treatment of type 2 diabetes. In: Feingold KR, Anawalt B, Blackman MR, et al., eds. Endotext. MDText.com, Inc.; 2000."}, {"Citation": "Rao PS, Mohan GK. In vitro alpha\u2010amylase inhibition and in vivo antioxidant potential of Momordica dioica seeds in streptozotocin\u2010induced oxidative stress in diabetic rats. Saudi J Biol Sci. 2017;24(6):1262\u20101267. doi:10.1016/j.sjbs.2016.01.010"}, {"Citation": "Visvanathan R, Qader M, Jayathilake C, Jayawardana BC, Liyanage R, Sivakanesan R. Critical review on conventional spectroscopic \u03b1\u2010amylase activity detection methods: merits, demerits, and future prospects. J Sci Food Agric. 2020;100(7):2836\u20102847. doi:10.1002/jsfa.10315"}, {"Citation": "Fleury L, Deracinois B, Dugardin C, et al. In vivo and in vitro comparison of the DPP\u2010IV inhibitory potential of food proteins from different origins after gastrointestinal digestion. Int J Mol Sci. 2022;23(15):8365. doi:10.3390/ijms23158365"}, {"Citation": "Yang SJ, Paudel P, Shrestha S, Seong SH, Jung HA, Choi JS. In vitro protein tyrosine phosphatase 1B inhibition and antioxidant property of different onion peel cultivars: a comparative study. Food Sci Nutr. 2019;7(1):205\u2010215. doi:10.1002/fsn3.863"}, {"Citation": "Saidu Y, Muhammad SA, Abbas AY, Onu A, Tsado IM, Muhammad L. In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants. J Intercult Ethnopharmacol. 2017;6(2):154\u2010157. doi:10.5455/jice.20161219011346"}, {"Citation": "Deora GS, Karthikeyan C, Moorthy NSHN, et al. Design, synthesis and biological evaluation of novel arylidine\u2010malononitrile derivatives as non\u2010carboxylic inhibitors of protein tyrosine phosphatase 1B. Med Chem Res. 2013;22(11):5344\u20105348. doi:10.1007/s00044\u2010013\u20100528\u20101"}, {"Citation": "Seong SH, Roy A, Jung HA, Jung HJ, Choi JS. Protein tyrosine phosphatase 1B and \u03b1\u2010glucosidase inhibitory activities of Pueraria lobata root and its constituents. J Ethnopharmacol. 2016;194:706\u2010716. doi:10.1016/j.jep.2016.10.007"}, {"Citation": "Paudel P, Yu T, Seong SH, Kuk EB, Jung HA, Choi JS. Protein tyrosine phosphatase 1B inhibition and glucose uptake potentials of mulberrofuran G, albanol B, and kuwanon G from root bark of Morus alba L. in insulin\u2010resistant HepG2 cells: an in vitro and in silico study. Int J Mol Sci. 2018;19(5):1542. https://doi.org/10.3390/ijms19051542"}, {"Citation": "Hsu B\u2010Y, Pan S\u2010Y, Wu L\u2010Y, Ho C\u2010T, Hwang LS. Hypoglycemic activity of Chenopodium formosanum Koidz. components using a glucose uptake assay with 3T3\u2010L1 adipocytes. Food Biosci. 2018;24:9\u201016. doi:10.1016/j.fbio.2018.05.001"}, {"Citation": "Blass BE. Chapter 4\u2014in vitro screening systems. In: Blass BE, ed. Basic Principles of Drug Discovery and Development. Academic Press; 2015:143\u2010202. doi:10.1016/B978\u20100\u201012\u2010411508\u20108.00004\u20109"}, {"Citation": "Jesus AR, Vila\u2010Vi\u00e7osa D, Machuqueiro M, Marques AP, Dore TM, Rauter AP. Targeting type 2 diabetes with C\u2010glucosyl dihydrochalcones as selective sodium glucose co\u2010transporter 2 (SGLT2) inhibitors: synthesis and biological evaluation. J Med Chem. 2017;60(2):568\u2010579. doi:10.1021/acs.jmedchem.6b01134"}, {"Citation": "Della MV, Cataldi P, Boi S, Finato N, Della PP, Beltrami CA. Image selection in static telepathology through the Internet. J Telemed Telecare. 1998;4(Suppl 1):20\u201022. doi:10.1258/1357633981931920"}, {"Citation": "Della MV, Cataldi P, Boi S, Finato N, Dalla PP, Beltrami CA. Image sampling in static telepathology for frozen section diagnosis. J Clin Pathol. 1999;52(10):761\u2010765. doi:10.1136/jcp.52.10.761"}, {"Citation": "Huang YT, Renne SL, Sollai M, et al. Clinical application of a real\u2010time telepathology system for frozen section diagnosis in comparison with optical microscope. Front Med. 2019;6:215. doi:10.3389/fmed.2019.00215"}, {"Citation": "Bleve G, Rizzotti L, Dellaglio F, Torriani S. Development of reverse transcription (RT)\u2010PCR and real\u2010time RT\u2010PCR assays for rapid detection and quantification of viable yeasts and molds contaminating yogurts and pasteurized food products. Appl Environ Microbiol. 2003;69(7):4116\u20104122. doi:10.1128/AEM.69.7.4116\u20104122.2003"}, {"Citation": "Diaz\u2010Vegas A, Norris DM, Jall\u2010Rogg S, et al. A high\u2010content endogenous GLUT4 trafficking assay reveals new aspects of adipocyte biology. Life Sci Alliance. 2023;6(1):6. doi:10.26508/lsa.202201585"}, {"Citation": "Levy J. Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease. Endocrine. 1999;10(1):1\u20106. doi:10.1385/ENDO:10:1:1"}, {"Citation": "Gomes Castro AJ, Cazarolli LH, Bretanha LC, et al. The potent insulin secretagogue effect of betulinic acid is mediated by potassium and chloride channels. Arch Biochem Biophys. 2018;648:20\u201026. doi:10.1016/j.abb.2018.04.015"}, {"Citation": "Schmidt S, Jakab M, Jav S, et al. Extracts from Leonurus sibiricus L. increase insulin secretion and proliferation of rat INS\u20101E insulinoma cells. J Ethnopharmacol. 2013;150(1):85\u201094. doi:10.1016/j.jep.2013.08.013"}, {"Citation": "Saji H, Nakajima N, Aono M, et al. Monitoring the escape of transgenic oilseed rape around Japanese ports and roadsides. Environ Biosaf Res. 2005;4(4):217\u2010222. doi:10.1051/ebr:2006003"}, {"Citation": "Hill SJ, Baker JG, Rees S. Reporter\u2010gene systems for the study of G\u2010protein\u2010coupled receptors. Curr Opin Pharmacol. 2001;1(5):526\u2010532. doi:10.1016/S1471\u20104892(01)00091\u20101"}, {"Citation": "Kotarsky K, Nilsson NE, Olde B, Owman C. Progress in methodology. Improved reporter gene assays used to identify ligands acting on orphan seven\u2010transmembrane receptors. Pharmacol Toxicol. 2003;93(6):249\u2010258. doi:10.1111/j.1600\u20100773.2003.pto930601.x"}, {"Citation": "Odeyemi S, Dewar J. In vitro antidiabetic activity affecting glucose uptake in HepG2 cells following their exposure to extracts of Lauridia tetragona (L.f.) R.H. Archer. Processes. 2019;8(1):33. doi:10.3390/pr8010033"}, {"Citation": "Sales PM, Souza PM, Simeoni LA, Silveira D. \u03b1\u2010Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci. 2012;15(1):141\u2010183. doi:10.18433/J35S3K"}, {"Citation": "Brayer GD, Luo Y, Withers SG. The structure of human pancreatic \u03b1\u2010amylase at 1.8\u2009\u00c5 resolution and comparisons with related enzymes. Protein Sci. 1995;4(9):1730\u20101742. doi:10.1002/pro.5560040908"}, {"Citation": "Odeyemi SW, Afolayan AJ. Identification of antidiabetic compounds from polyphenolic\u2010rich fractions of Bulbine abyssinica A. rich leaves. Pharmacognosy Res. 2018;10(1):72\u201080. doi:10.4103/pr.pr_55_17"}, {"Citation": "Proen\u00e7a C, Freitas M, Ribeiro D, et al. The dipeptidyl peptidase\u20104 inhibitory effect of flavonoids is hindered in protein rich environments. Food Funct. 2019;10(9):5718\u20105731. doi:10.1039/C9FO00722A"}, {"Citation": "Zhu G, Fang Q, Zhu F, Huang D, Yang C. Structure and function of pancreatic lipase\u2010related protein 2 and its relationship with pathological states. Front Genet. 2021;12:693538. doi:10.3389/fgene.2021.693538"}, {"Citation": "Sellami M, Louati H, Kamoun J, Kchaou A, Damak M, Gargouri Y. Inhibition of pancreatic lipase and amylase by extracts of different spices and plants. Int J Food Sci Nutr. 2017;68(3):313\u2010320. doi:10.1080/09637486.2016.1237479"}, {"Citation": "Kim YS, Lee YM, Kim H, et al. Anti\u2010obesity effect of Morus bombycis root extract: anti\u2010lipase activity and lipolytic effect. J Ethnopharmacol. 2010;130(3):621\u2010624. doi:10.1016/j.jep.2010.05.053"}, {"Citation": "Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms. J Endocrinol. 2014;220(2):T1\u2010t23. doi:10.1530/JOE\u201013\u20100327"}, {"Citation": "Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol. 2000;2(3):156\u2010162. doi:10.1038/35004029"}, {"Citation": "Bakke J, Haj FG. Protein\u2010tyrosine phosphatase 1B substrates and metabolic regulation. Semin Cell Dev Biol. 2015;37:58\u201065. doi:10.1016/j.semcdb.2014.09.020"}, {"Citation": "Teimouri M, Hosseini H, ArabSadeghabadi Z, Babaei\u2010Khorzoughi R, Gorgani\u2010Firuzjaee S, Meshkani R. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications. J Physiol Biochem. 2022;78(2):307\u2010322. doi:10.1007/s13105\u2010021\u201000860\u20107"}, {"Citation": "Tiong SH, Looi CY, Hazni H, et al. Antidiabetic and antioxidant properties of alkaloids from Catharanthus roseus (L.) G. Don. Molecules (Basel, Switzerland). 2013;18(8):9770\u20109784."}, {"Citation": "Yamamoto N, Ueda\u2010Wakagi M, Sato T, et al. Measurement of glucose uptake in cultured cells. Curr Protoc Pharmacol. 2015;71:12\u201014."}, {"Citation": "Yamamoto N, Ashida H. Evaluation methods for facilitative glucose transport in cells and their applications. Food Sci Technol Res. 2012;18(4):493\u2010503. doi:10.3136/fstr.18.493"}, {"Citation": "Bahrami G, Miraghaee SS, Mohammadi B, et al. Molecular mechanism of the anti\u2010diabetic activity of an identified oligosaccharide from Rosa canina. Res Pharm Sci. 2020;15(1):36\u201047. doi:10.4103/1735\u20105362.278713"}, {"Citation": "Khazaei M, Pazhouhi M. Protective effect of hydroalcoholic extracts of Trifolium pratense L. on pancreatic \u03b2 cell line (RIN\u20105F) against cytotoxicty of streptozotocin. Res Pharm Sci. 2018;13(4):324\u2010331. doi:10.4103/1735\u20105362.235159"}, {"Citation": "Lv Y, Ren W, Zhang Y, et al. Antidiabetic effects of a lipophilic extract obtained from flowers of Wisteria sinensis by activating Akt/GLUT4 and Akt/GSK3\u03b2. Food Nutr Res. 2020;64(0):64. doi:10.29219/fnr.v64.3589"}, {"Citation": "Hu Y, Chen Y, Ding L, et al. Pathogenic role of diabetes\u2010induced PPAR\u2010\u03b1 down\u2010regulation in microvascular dysfunction. Proc Natl Acad Sci USA. 2013;110(38):15401\u201015406. doi:10.1073/pnas.1307211110"}, {"Citation": "Celi FS, Shuldiner AR. The role of peroxisome proliferator\u2010activated receptor gamma in diabetes and obesity. Curr Diab Rep. 2002;2(2):179\u2010185. doi:10.1007/s11892\u2010002\u20100078\u20102"}, {"Citation": "Colin\u2010Lozano B, Torres\u2010Gomez H, Hidalgo\u2010Figueroa S, et al. Synthesis, in vitro, in vivo and in silico antidiabetic bioassays of 4\u2010nitro(thio)phenoxyisobutyric acids acting as unexpected PPAR\u03b3 modulators: an in combo study. Pharmaceuticals (Basel, Switzerland). 2022;15(1):15. doi:10.3390/ph15010102"}, {"Citation": "Ansari P, Flatt PR, Harriott P, Abdel\u2010Wahab YHA. Insulin secretory and antidiabetic actions of Heritiera fomes bark together with isolation of active phytomolecules. PLoS ONE. 2022;17(3):e0264632. doi:10.1371/journal.pone.0264632"}, {"Citation": "Nakajima Y, Ohmiya Y. Bioluminescence assays: multicolor luciferase assay, secreted luciferase assay and imaging luciferase assay. Expert Opin Drug Discov. 2010;5(9):835\u2010849. doi:10.1517/17460441.2010.506213"}, {"Citation": "Yeo J, Kang YM, Cho SI, Jung MH. Effects of a multi\u2010herbal extract on type 2 diabetes. Chin Med. 2011;6(1):10. doi:10.1186/1749\u20108546\u20106\u201010"}, {"Citation": "Sagbo IJ, van de Venter M, Koekemoer T, Bradley G. In vitro antidiabetic activity and mechanism of action of Brachylaena elliptica (Thunb.) DC. Evid Based Complement Alternat Med: eCAM. 2018;2018:4170372. doi:10.1155/2018/4170372"}, {"Citation": "King AJ. The use of animal models in diabetes research. Br J Pharmacol. 2012;166(3):877\u2010894. doi:10.1111/j.1476\u20105381.2012.01911.x"}, {"Citation": "Dufrane D, van Steenberghe M, Guiot Y, Goebbels R\u2010M, Saliez A, Gianello P. Streptozotocin\u2010induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and \u03b2\u2010cell plasticity. Transplantation. 2006;81(1):36\u201045. doi:10.1097/01.tp.0000189712.74495.82"}, {"Citation": "Baily C, Baily O. Production of diabetes mellitus in rabbits with alloxan. A preliminary report. J am Med. 1943;122(17):1165\u20101166. doi:10.1001/jama.1943.02840340013004"}, {"Citation": "Bansal R, Ahmad N, Kidwai JR. Alloxan\u2010glucose interaction: effect on incorporation of 14C\u2010leucine into pancreatic islets of rat. Acta Diabetol Lat. 1980;17(2):135\u2010143. doi:10.1007/BF02580995"}, {"Citation": "Lee JH, Yang SH, Oh JM, Lee MG. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus. J Pharm Pharmacol. 2010;62(1):1\u201023. doi:10.1211/jpp.62.01.0001"}, {"Citation": "Masiello P. Animal models of type 2 diabetes with reduced pancreatic \u03b2\u2010cell mass. Int J Biochem Cell Biol. 2006;38(5\u20106):873\u2010893. doi:10.1016/j.biocel.2005.09.007"}, {"Citation": "Kumar S, Singh R, Vasudeva N, Sharma S. Acute and chronic animal models for the evaluation of anti\u2010diabetic agents. Cardiovasc Diabetol. 2012;11(1):1\u201013. doi:10.1186/1475\u20102840\u201011\u20109"}, {"Citation": "Vogel HG, Vogel WH, Vogel HG, M\u00fcller G, Sandow J, Sch\u00f6lkens BA. Drug Discovery and Evaluation: Pharmacological Assays. Springer; 1997. doi:10.1007/978\u20103\u2010662\u201003333\u20103"}, {"Citation": "Frerichs H, Creutzfeldt W. Der experimentelle chemische Diabetes. Springer\u2010Verlag; 1971."}, {"Citation": "Botolin S, McCabe LR. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology. 2007;148(1):198\u2010205. doi:10.1210/en.2006\u20101006"}, {"Citation": "Nyman JS, Even JL, Jo CH, et al. Increasing duration of type 1 diabetes perturbs the strength\u2013structure relationship and increases brittleness of bone. Bone. 2011;48(4):733\u2010740. doi:10.1016/j.bone.2010.12.016"}, {"Citation": "Silva MJ, Brodt MD, Lynch MA, et al. Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res. 2009;24(9):1618\u20101627. doi:10.1359/jbmr.090316"}, {"Citation": "Schmidt RE, Dorsey DA, Beaudet LN, et al. Non\u2010obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. Am J Pathol. 2003;163(5):2077\u20102091. doi:10.1016/S0002\u20109440(10)63565\u20101"}, {"Citation": "von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol. 2009;10(2):129\u2010132. doi:10.1038/ni0209\u2010129"}, {"Citation": "von Herrath MG, Nepom GT. Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity. J Exp Med. 2005;202(9):1159\u20101162. doi:10.1084/jem.20051224"}, {"Citation": "Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med. 2005;22(4):359\u2010370. doi:10.1111/j.1464\u20105491.2005.01499.x"}, {"Citation": "Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J. 2004;45(3):278\u2010291. doi:10.1093/ilar.45.3.278"}, {"Citation": "Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol. 2005;23(1):447\u2010485. doi:10.1146/annurev.immunol.23.021704.115643"}, {"Citation": "Yokoi N, Namae M, Fuse M, et al. Establishment and characterization of the Komeda diabetes\u2010prone rat as a segregating inbred strain. Exp Anim. 2003;52(4):295\u2010301. doi:10.1538/expanim.52.295"}, {"Citation": "Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. New inbred strain of Long\u2010Evans Tokushima lean rats with IDDM without lymphopenia. Diabetes. 1991;40(11):1375\u20101381. doi:10.2337/diab.40.11.1375"}, {"Citation": "Eisenbarth GS. Type 1 diabetes: molecular, cellular and clinical immunology. Adv Exp Med Biol. 2004;552:306\u2010310."}, {"Citation": "Komeda K, Noda M, Terao K, Kuzuya N, Kanazawa M, Kanazawa Y. Establishment of two substrains, diabetes\u2010prone and non\u2010diabetic, from Long\u2010Evans Tokushima Lean (LETL) rats. Endocr J. 1998;45(6):737\u2010744. doi:10.1507/endocrj.45.737"}, {"Citation": "Lenzen S. Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes. Diabetes Metab Res Rev. 2017;33(7):e2915. doi:10.1002/dmrr.2915"}, {"Citation": "Al\u2010Awar A, Kupai K, Veszelka M, et al. Experimental diabetes mellitus in different animal models. J Diabetes Res. 2016;2016:9051426. doi:10.1155/2016/9051426"}, {"Citation": "Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R. Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology. 2015;484:288\u2010304. doi:10.1016/j.virol.2015.06.006"}, {"Citation": "Ja\u00efdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008;34(6):537\u2010548. doi:10.1016/j.diabet.2008.05.008"}, {"Citation": "Kemball CC, Alirezaei M, Whitton JL. Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol. 2010;5(9):1329\u20101347. doi:10.2217/fmb.10.101"}, {"Citation": "Garmaroudi FS, Marchant D, Hendry R, et al. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10(4):629\u2010653. doi:10.2217/fmb.15.5"}, {"Citation": "Rakieten N, Rakieten ML, Nadkarni MR. Studies on the diabetogenic action of streptozotocin (NSC\u201037917). Cancer Chemother Rep. 1963;29:91\u201098."}, {"Citation": "Wu J, Yan L\u2010J. Streptozotocin\u2010induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic \u03b2 cell glucotoxicity. Diabetes Metab Syndr Obes: Targets Ther. 2015;8:181. doi:10.2147/DMSO.S82272"}, {"Citation": "Lenzen S. The mechanisms of alloxan\u2010 and streptozotocin\u2010induced diabetes. Diabetologia. 2008;51(2):216\u2010226. doi:10.1007/s00125\u2010007\u20100886\u20107"}, {"Citation": "Furman BL. Streptozotocin\u2010induced diabetic models in mice and rats. Curr Protoc Pharmacol. 2015;70:5\u201047."}, {"Citation": "Krisanapun C, Peungvicha P, Temsiririrkkul R, Wongkrajang Y. Aqueous extract of Abutilon indicum Sweet inhibits glucose absorption and stimulates insulin secretion in rodents. Nutr Res. 2009;29(8):579\u2010587. doi:10.1016/j.nutres.2009.07.006"}, {"Citation": "Thayer TC, Wilson SB, Mathews CE. Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinol Metab Clin. 2010;39(3):541\u2010561. doi:10.1016/j.ecl.2010.05.001"}, {"Citation": "Qi W, Keenan HA, Li Q, et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 2017;23(6):753\u2010762. doi:10.1038/nm.4328"}, {"Citation": "Ravichandra V, Paarakh P. Evaluation of anti\u2010diabetic potentials of methanolic extract of Ficus microcarpa leaves in alloxan induced diabetic rats. Int J Pharm Pharm Sci. 2013;5:369\u2010373."}, {"Citation": "Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50:537\u2010546."}, {"Citation": "im Walde SS, Dohle C, Schott\u2010Ohly P, Gleichmann H. Molecular target structures in alloxan\u2010induced diabetes in mice. Life Sci. 2002;71(14):1681\u20101694. doi:10.1016/S0024\u20103205(02)01918\u20105"}, {"Citation": "Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper E. The use of animal models in the study of diabetes mellitus. In Vivo. 2009;23:245\u2010258."}, {"Citation": "Wicker LS, Clark J, Fraser HI, et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun. 2005;25:29\u201033. doi:10.1016/j.jaut.2005.09.009"}, {"Citation": "Caquard M, Ferret\u2010Bernard S, Haurogn\u00e9 K, et al. Diabetes acceleration by cyclophosphamide in the non\u2010obese diabetic mouse is associated with differentiation of immunosuppressive monocytes into immunostimulatory cells. Immunol Lett. 2010;129(2):85\u201093. doi:10.1016/j.imlet.2010.01.009"}, {"Citation": "Yang Y, Santamaria P. Dissecting autoimmune diabetes through genetic manipulation of non\u2010obese diabetic mice. Diabetologia. 2003;46(11):1447\u20101464. doi:10.1007/s00125\u2010003\u20101218\u20101"}, {"Citation": "Niens M, Grier AE, Marron M, Kay TW, Greiner DL, Serreze DV. Prevention of \u201chumanized\u201d diabetogenic CD8 T\u2010cell responses in HLA\u2010transgenic NOD mice by a multipeptide coupled\u2010cell approach. Diabetes. 2011;60(4):1229\u20101236. doi:10.2337/db10\u20101523"}, {"Citation": "Holmberg R, Refai E, H\u00f6\u00f6g A, et al. Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proc Natl Acad Sci. 2011;108(26):10685\u201010689. doi:10.1073/pnas.1019553108"}, {"Citation": "Zhang W, Kamiya H, Ekberg K, Wahren J, Sima AA. C\u2010peptide improves neuropathy in type 1 diabetic BB/Wor\u2010rats. Diabetes Metab Res Rev. 2007;23(1):63\u201070. doi:10.1002/dmrr.672"}, {"Citation": "Yokoi N, Kanazawa M, Kitada K, et al. A non\u2010MHC locus essential for autoimmune type I diabetes in the Komeda Diabetes\u2010Prone rat. J Clin Invest. 1997;100(8):2015\u20102021. doi:10.1172/JCI119733"}, {"Citation": "Yokoi N, Hayashi C, Fujiwara Y, Wang H\u2010Y, Seino S. Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat. Diabetes. 2007;56(2):506\u2010512. doi:10.2337/db06\u20101027"}, {"Citation": "Ishida K, Mizuno A, Min Z, Sano T, Shima K. Which is the primary etiologic event in Otsuka Long\u2010Evans Tokushima Fatty rats, a model of spontaneous non\u2010insulin\u2010dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism. 1995;44(7):940\u2010945. doi:10.1016/0026\u20100495(95)90249\u2010X"}, {"Citation": "Mathews CE. Utility of murine models for the study of spontaneous autoimmune type 1 diabetes. Pediatr Diabetes. 2005;6(3):165\u2010177. doi:10.1111/j.1399\u2010543X.2005.00123.x"}, {"Citation": "Peschke E, Hofmann K, B\u00e4hr I, et al. The insulin\u2013melatonin antagonism: studies in the LEW.1AR1\u2010iddm rat (an animal model of human type 1 diabetes mellitus). Diabetologia. 2011;54(7):1831\u20101840. doi:10.1007/s00125\u2010011\u20102138\u20100"}, {"Citation": "J\u00f6rns A, Kubat B, Tiedge M, et al. Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm\u2010iddm rat, a new model of spontaneous insulin\u2010dependent diabetes mellitus. Virchows Arch. 2004;444(2):183\u2010189. doi:10.1007/s00428\u2010003\u20100956\u20102"}, {"Citation": "Mathews CE, Langley SH, Leiter EH. New mouse model to study islet transplantation in insulin\u2010dependent diabetes mellitus. Transplantation. 2002;73(8):1333\u20101336. doi:10.1097/00007890\u2010200204270\u201000024"}, {"Citation": "Zhou C, Pridgen B, King N, Xu J, Breslow JL. Hyperglycemic Ins2AkitaLdlr\u2212/\u2212 mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease[S]. J Lipid Res. 2011;52(8):1483\u20101493. doi:10.1194/jlr.M014092"}, {"Citation": "Drel VR, Pacher P, Stavniichuk R, et al. Poly(ADP\u2010ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice. Int J Mol Med. 2011;28(4):629\u2010635. doi:10.3892/ijmm.2011.709"}, {"Citation": "Chen H, Zheng C, Zhang X, et al. Apelin alleviates diabetes\u2010associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides. 2011;32(8):1634\u20101639. doi:10.1016/j.peptides.2011.06.025"}, {"Citation": "Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses\u2014some recent developments. Diabetologia. 1993;36(8):687\u2010695. doi:10.1007/BF00401138"}, {"Citation": "Ja\u00efdane H, San\u00e9 F, Gharbi J, Aouni M, Romond MB, Hober D. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev. 2009;25(7):591\u2010603. doi:10.1002/dmrr.995"}, {"Citation": "Yoon J\u2010W, Jun H\u2010S. Viruses cause type 1 diabetes in animals. Ann N Y Acad Sci. 2006;1079(1):138\u2010146. doi:10.1196/annals.1375.021"}, {"Citation": "Mendez II, Chung Y\u2010H, Jun H\u2010S, Yoon J\u2010W. Immunoregulatory role of nitric oxide in Kilham rat virus\u2010induced autoimmune diabetes in DR\u2010BB rats1. J Immunol. 2004;173(2):1327\u20101335. doi:10.4049/jimmunol.173.2.1327"}, {"Citation": "Onodera T, Jenson AB, Yoon J\u2010W, Notkins AL. Virus\u2010induced diabetes mellitus: reovirus infection of pancreatic \u03b2 cells in mice. Science. 1978;201(4355):529\u2010531. doi:10.1126/science.208156"}, {"Citation": "Filippi CM, Herrath MGv. Good and bad sides of viruses in Type 1 diabetes. Future Virol. 2009;4(5):407\u2010410. doi:10.2217/fvl.09.28"}, {"Citation": "Chung YH, Jun HS, Kang Y, et al. Role of macrophages and macrophage\u2010derived cytokines in the pathogenesis of Kilham rat virus\u2010induced autoimmune diabetes in diabetes\u2010resistant BioBreeding rats. J Immunol. 1997;159(1):466\u2010471. doi:10.4049/jimmunol.159.1.466"}, {"Citation": "Talebianpoor MS, Talebianpoor MS, Mansourian M, Vafaiee\u2010Nejad T. Antidiabetic activity of hydroalcoholic extract of Myrtus communis (Myrtle) fruits in streptozotocin\u2010induced and dexamethasone\u2010induced diabetic rats. Pharmacognosy Res. 2019;11."}, {"Citation": "Moloney P, Coval M. Antigenicity of insulin: diabetes induced by specific antibodies. Biochem J. 1955;59(2):179\u2010185. doi:10.1042/bj0590179"}, {"Citation": "Dewangan H, Tiwari RK, Sharma V, Shukla SS, Satapathy T, Pandey R. Past and future of in\u2010vitro and in\u2010vivo animal models for diabetes: a review. Indian J Pharm Educ Res. 2017;51(4s):s522\u2010s530. doi:10.5530/ijper.51.4s.79"}, {"Citation": "Nagata M, Suzuki W, Iizuka S, et al. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Exp Anim. 2006;55(2):109\u2010115. doi:10.1538/expanim.55.109"}, {"Citation": "Karasawa H, Takaishi K, Kumagae Y. Obesity\u2010induced diabetes in mouse strains treated with gold thioglucose: a novel animal model for studying \u03b2\u2010cell dysfunction. Obesity. 2011;19(3):514\u2010521. doi:10.1038/oby.2010.171"}, {"Citation": "Kottaisamy CPD, Raj DS, Prasanth KV, Sankaran U. Experimental animal models for diabetes and its related complications\u2014a review. Lab Anim Res. 2021;37:1\u201014."}, {"Citation": "Lindstr\u00f6m P. The physiology of obese\u2010hyperglycemic mice [ob/ob mice]. Sci World J. 2007;7:666\u2010685. doi:10.1100/tsw.2007.117"}, {"Citation": "Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S. P633H, a novel dual agonist at peroxisome proliferator\u2010activated receptors \u03b1 and \u03b3, with different anti\u2010diabetic effects in db/db and KK\u2010Ay mice. Br J Pharmacol. 2009;157(5):724\u2010735. doi:10.1111/j.1476\u20105381.2009.00231.x"}, {"Citation": "Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res. 2007;125:451."}, {"Citation": "Loos RJF, Janssens A. Predicting polygenic obesity using genetic information. Cell Metab. 2017;25(3):535\u2010543. doi:10.1016/j.cmet.2017.02.013"}, {"Citation": "Chakraborty G, Thumpayil S, Lafontant D\u2010E, Woubneh W, Toney JH. Age dependence of glucose tolerance in adult KK\u2010Ay mice, a model of non\u2010insulin dependent diabetes mellitus. Lab Anim. 2009;38(11):364\u2010368. doi:10.1038/laban1109\u2010364"}, {"Citation": "Kim JH, Stewart TP, Zhang W, Kim HY, Nishina PM, Naggert JK. Type 2 diabetes mouse model TallyHo carries an obesity gene on chromosome 6 that exaggerates dietary obesity. Physiol Genomics. 2005;22(2):171\u2010181. doi:10.1152/physiolgenomics.00197.2004"}, {"Citation": "Cho Y\u2010R, Kim H\u2010J, Park S\u2010Y, et al. Hyperglycemia, maturity\u2010onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes. Am J Physiol\u2010Endocrinol Metab. 2007;293(1):E327\u2010E336. doi:10.1152/ajpendo.00376.2006"}, {"Citation": "Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long\u2010Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract. 1994;24:S317\u2010S320. doi:10.1016/0168\u20108227(94)90269\u20100"}, {"Citation": "Friedman JE, Ishizuka T, Liu S, Bedol D, Koletsky RJ, Ernsberger P. Metabolic consequences of a nonsense mutation in the leptin receptor gene (fak) in the obeses spontaneously hypertensive Koletsky rat (SHROB). Exp Clin Endocrinol Diabetes. 1997;105(S 03):82\u201084. doi:10.1055/s\u20100029\u20101211908"}, {"Citation": "Tarr\u00e9s M, Mart\u00ednez S, Montenegro S, Llorens A, Picena J, Naves A. The eSS rat. A model of non\u2010insulin\u2010dependent human diabetes. Am J Pathol. 1992;141:761."}, {"Citation": "H\u00f6ppener J.W.M., Jacobs H.M., Wierup N., Sotthewes G., Sprong M., de Vos P., Berger R., Sundler F., Ahr\u00e9n B. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus. Exp Diabetes Res (2008) 2008, 697035. doi:10.1155/2008/697035."}, {"Citation": "Matveyenko AV, Gurlo T, Daval M, Butler AE, Butler PC. Successful versus failed adaptation to high\u2010fat diet\u2010induced insulin resistance: the role of IAPP\u2010induced \u03b2\u2010cell endoplasmic reticulum stress. Diabetes. 2009;58(4):906\u2010916. doi:10.2337/db08\u20101464"}, {"Citation": "Xue B, Sukumaran S, Nie J, Jusko WJ, DuBois DC, Almon RR. Adipose tissue deficiency and chronic inflammation in diabetic Goto\u2010Kakizaki rats. PLoS ONE. 2011;6(2):e17386. doi:10.1371/journal.pone.0017386"}], "Title": "REFERENCES"}], "History": [{"Year": "2024", "Month": "2", "Day": "26"}, {"Year": "2023", "Month": "9", "Day": "14"}, {"Year": "2024", "Month": "4", "Day": "25"}, {"Year": "2024", "Month": "5", "Day": "15", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "15", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "15", "Hour": "5", "Minute": "3"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38747157", "10.1111/fcp.13009"]}}]}